Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IQ calmodulin-binding motif-containing protein 1 (IQCB1), also called nephrocystin-5 (NPHP5), is a ubiquitously expressed ciliary protein encoded by the IQCB1 gene located on human chromosome 3q13.33[1][2]. It contains IQ domains for calmodulin binding and is essential for ciliogenesis, particularly in the development and maintenance of structures such as photoreceptor outer segments in the retina. Mutations in IQCB1 are causative for rare autosomal recessive ciliopathies, especially Senior-Løken syndrome, which combines nephronophthisis (a chronic kidney disorder) with early-onset retinal degeneration (Leber congenital amaurosis). Pathogenic IQCB1 variants disrupt photoreceptor structure and renal function. There are currently no therapies that target IQCB1 directly; its value is principally in genetic diagnosis and understanding the pathogenesis of cilia-related diseases[2][4][8].
Not applicable (no approved drugs targeting IQCB1)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IQ calmodulin-binding motif-containing protein 1 (IQCB1).